Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/231258
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression |
Autor: | Blanco-Gómez, Adrián CSIC ORCID; Hontecillas-Prieto, Lourdes CSIC ORCID; Corchado Cobos, Roberto CSIC ORCID; García-Sancha, Natalia CSIC ORCID; Salvador, Nélida; Castellanos-Martín, Andrés CSIC ORCID; Sáez-Freire, María del Mar; Mendiburu-Eliçabe, Marina CSIC ORCID; Alonso-López, D. CSIC ORCID; Rivas, Javier de las ; Lorente, Mar CSIC; García-Casas, Ana; Carmen, Sofía del; Abad-Hernández, María del Mar; Cruz, Juan Jesús CSIC ORCID; Rodríguez-Sánchez, César Augusto; Claros-Ampuero, Juncal; García-Cenador, Begoña; García-Criado, Francisco Javier; Orimo, Akira; Gridley, Thomas; Pérez-Losada, J. CSIC ORCID ; Castillo, Sonia CSIC ORCID | Fecha de publicación: | dic-2020 | Editor: | American Association for Cancer Research | Citación: | Cancer Research 80(23): 5216-5230 (2020) | Resumen: | SNAI2 overexpression appears to be associated with poor prognosis in breast cancer, yet it remains unclear in which breast cancer subtypes this occurs. Here we show that excess SNAI2 is associated with a poor prognosis of luminal B HER2+/ERBB2+ breast cancers in which SNAI2 expression in the stroma but not the epithelium correlates with tumor proliferation. To determine how stromal SNAI2 might influence HER2+ tumor behavior, Snai2-deficient mice were crossed with a mouse line carrying the ErbB2/Neu protooncogene to generate HER2+/ERBB2+ breast cancer. Tumors generated in this model expressed SNAI2 in the stroma but not the epithelium, allowing for the role of stromal SNAI2 to be studied without interference from the epithelial compartment. The absence of SNAI2 in the stroma of HER2+/ERBB2+ tumors is associated with: (i) lower levels of cyclin D1 (CCND1) and reduced tumor epithelium proliferation; (ii) higher levels of AKT and a lower incidence of metastasis; (iii) lower levels of angiopoietin-2 (ANGPT2), and more necrosis. Together, these results indicate that the loss of SNAI2 in cancer-associated fibroblasts limits the production of some cytokines, which influences AKT/ERK tumor signaling and subsequent proliferative and metastatic capacity of ERBB2+ breast cancer cells. Accordingly, SNAI2 expression in the stroma enhanced the tumorigenicity of luminal B HER2+/ERBB2+ breast cancers. This work emphasizes the importance of stromal SNAI2 in breast cancer progression and patients' prognosis. | Versión del editor: | http://dx.doi.org/10.1158/0008-5472.CAN-20-0278 | URI: | http://hdl.handle.net/10261/231258 | DOI: | 10.1158/0008-5472.CAN-20-0278 | ISSN: | 0008-5472 | E-ISSN: | 1538-7445 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Stromal_Blanco_Art2020_Postprint.pdf | 13,73 MB | Adobe PDF | Visualizar/Abrir | |
2__236261_3_supp_6603913_qh7ymd_1.pdf | 1,05 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
13
checked on 20-abr-2024
SCOPUSTM
Citations
15
checked on 29-abr-2024
WEB OF SCIENCETM
Citations
16
checked on 24-feb-2024
Page view(s)
104
checked on 03-may-2024
Download(s)
121
checked on 03-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.